The Accuracy of the Uganda National Tuberculosis and Leprosy Program algorithm and the World Health Organisation treatment decision algorithms for childhood tuberculosis: A retrospective analysis
Kitonsa, P. J.; Kikaire, B.; Wambi, P.; Nalutaaya, A.; Nakafeero, J.; Nanyonga, G.; Kiconco, E.; Atwiine, D.; Castro, R.; Oumo, E. A.; Aanyu, H. T.; Mudiope, M. N.; Mupere, E.; Sekadde, M. P.; Mohanty, S.; Cattamanchi, A.; Wobudeya, E.; Jaganath, D.
Show abstract
Diagnosing childhood pulmonary tuberculosis (TB) is a challenge, and this led the Uganda National Tuberculosis and Leprosy Program (NTLP) to develop a clinical treatment decision algorithm (TDA) for children. However, there is limited data on its accuracy and how it compares to new World Health Organization (WHO) TB TDAs for children. This study aimed to evaluate and compare the accuracy of the 2017 Uganda NTLP algorithm with the 2022 WHO TDAs for TB among children in Kampala, Uganda. We retrospectively assessed children <15 years old who underwent an evaluation for TB between November 2018 and November 2022. Children were classified as per National Institutes of Health (NIH) consensus definitions. We applied the 2017 Uganda NTLP and 2022 WHO algorithms (A with chest x-ray [CXR], B without CXR) to make a decision to treat for TB or not, and calculated accuracy in reference to Confirmed vs. Unlikely TB, as well as a microbiological and composite reference standard. We compared accuracy of the Uganda NTLP algorithm to the WHO TDAs among children <10 years old. A total of 699 children were included in this analysis with 64% (451/699) under 5 years, 53% (373/669) were male, 12% (85/699) were Xpert Ultra positive, 11% (74/669) were HIV positive and 6% had severe acute malnutrition (SAM). The Uganda NTLP algorithm had a sensitivity of 97.9% (95% CI: 96.4-99.4) and specificity of 25.9% (95% CI: 21.2-30.7). If CXR was considered unavailable, sensitivity was 97.9% (95% CI: 96.4-99.4) and specificity 28.1% (95% CI: 23.2-33.0). Accuracy remained similar among high-risk children. In comparison, WHO TDAs had similar sensitivity to the Uganda NTLP, but algorithm A was more specific (32.2%, 95% CI: 26.9-37.5) and algorithm B was less specific (15.4%, 95% CI: 11.3-19.5). Both the Uganda NTLP and WHO TDAs had high sensitivity but low specificity. The WHO TDAs had better specificity than the NTLP algorithm with CXR, and worse specificity without CXR. Further optimization of the algorithms is needed to improve specificity and reduce over-treatment of TB in children.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda 98%
- Outcomes of Isoniazid Preventive Therapy among people living with HIV in Kenya: A retrospective study of routine health care data 96%
- High Proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia 96%
Similar papers in this journal
- Evaluating the health impact, health-system costs and cost-effectiveness of using TrueNat on stool samples compared to usual care for the diagnosis of paediatric tuberculosis in primary care settings: a modelling analysis 96%
- Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru 95%
- Higher loss of livelihood and impoverishment in households affected by tuberculosis compared to non-tuberculosis affected households in Zimbabwe: a cross-sectional study 95%
Similar papers in this journal
- Tuberculosis services delivery challenges and their mitigations during the COVID-19 pandemic in Tanzania: A qualitative study 94%
- Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study 94%
- Evaluating the PATHFAST TB LAM Ag Assay as a Treatment Monitoring Tool for Pulmonary Tuberculosis : Protocol for a Prospective Longitudinal Study in Nairobi, Kenya 94%
Similar papers in this journal
- C-reactive protein for pulmonary tuberculosis screening and treatment response monitoring in children 97%
- Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries 95%
- Programmatic diagnostic accuracy and clinical utility of Xpert MTB/XDR in patients with rifampicin-resistant tuberculosis in Georgia 94%
Similar papers in this journal
- Private sector tuberculosis care quality during the COVID-19 pandemic: A repeated cross-sectional standardized patients study of adherence to national TB guidelines in urban Nigeria 94%
- Determinants of losses in the latent tuberculosis infection cascade of care in Brazil: a prospective multicenter cohort study 94%
- Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV. A IeDEA Pediatric West African cohort analysis 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.